Iora Health is a healthcare company and developer of a high-impact relationship based care model intended to improve the lives of our patients while lowering costs.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/10/2020 | Series F | $150MM | $xx.xx | $790.13MM | .406 Ventures, Cox Enterprises, Devonshire Investors, Flare Capital Partners, Khosla Venture, Polaris Partners, Premji Invest, Temasek | |
Price per Share
$xx.xx
Shares Outstanding
15,806,111
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Cox Enterprises, Devonshire Investors, Flare Capital Partners, Khosla Venture, Polaris Partners, Premji Invest, Temasek
|
||||||
09/28/2018 | Series E3 | $15MM | $xx.xx | $575MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,778,515
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/21/2018 | Series E2 | $39.1MM | $xx.xx | $499.73MM | .406 Ventures, Devonshire Investors, Flare Capital Partners, F-Prime Capital, Ge Ventures, Humana, Khosla Ventures, Polaris Partners, Temasek | |
Price per Share
$xx.xx
Shares Outstanding
5,097,633
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Devonshire Investors, Flare Capital Partners, F-Prime Capital, Ge Ventures, Humana, Khosla Ventures, Polaris Partners, Temasek
|
||||||
05/21/2018 | Series E | $60.9MM | $xx.xx | $499.73MM | .406 Ventures, Devonshire Investors, Flare Capital Partners, F-Prime Capital, Ge Ventures, Humana, Khosla Ventures, Polaris Partners, Temasek | |
Price per Share
$xx.xx
Shares Outstanding
7,940,177
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Devonshire Investors, Flare Capital Partners, F-Prime Capital, Ge Ventures, Humana, Khosla Ventures, Polaris Partners, Temasek
|
||||||
10/13/2016 | Series D2 | $2.96MM | $xx.xx | $265MM | .406 Ventures, Flare Capital Partners, F-Prime Capital, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company, Temasek | |
Price per Share
$xx.xx
Shares Outstanding
530,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Flare Capital Partners, F-Prime Capital, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company, Temasek
|
||||||
10/13/2016 | Series D | $72.03MM | $xx.xx | $265MM | .406 Ventures, Flare Capital Partners, F-Prime Capital, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company, Temasek | |
Price per Share
$xx.xx
Shares Outstanding
12,899,874
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Flare Capital Partners, F-Prime Capital, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company, Temasek
|
||||||
10/09/2015 | Series C2 | $15.61MM | $xx.xx | $114.89MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,778,567
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/26/2015 | Series C | $27.43MM | $xx.xx | $106.84MM | .406 Ventures, Fidelity, Foundation Medical Partners, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company | |
Price per Share
$xx.xx
Shares Outstanding
8,398,170
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Fidelity, Foundation Medical Partners, Ge Ventures, Khosla Ventures, Polaris Partners, Rice Management Company
|
||||||
04/15/2013 | Series B | $10.86MM | $xx.xx | $41.59MM | .406 Ventures, F-Prime Capital, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,303,059
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, F-Prime Capital, Polaris Partners
|
||||||
10/24/2011 | Series A | $6.25MM | $xx.xx | $16MM | .406 Ventures, Eight Roads, Oxeon Partners, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,250,000
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
.406 Ventures, Eight Roads, Oxeon Partners, Polaris Partners
|